로딩 중…
지수 로딩 중…
MOA Life Plus Co. Ltd.
142760· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩590-4.99%
2026-06-19
Price Chart
MOA Life Plus Co. Ltd.-70.86%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 24.88B KRW |
| Revenue | 10.45B KRW |
| Net Income | -12.81B KRW |
| Total Assets | 43.38B KRW |
| Net Assets | 31.99B KRW |
| Employees | 59 |
| Value | |
| P/B | 0.78x |
| P/S | 2.38x |
| FCF Yield | -24.43% |
| Profitability | |
| ROE | -40.05% |
| ROA | -29.53% |
| Op. Margin | -65.19% |
| Revenue Growth | -24.70% |
| Financial Health | |
| Debt Ratio | 135.62% |
| Total Debt | 14.73B KRW |
| FCF | -6.08B KRW |
| Cash | 3.59B KRW |
| Current Ratio | 1.99x |
| Performance | |
| 1Y Return | -70.86% |
| 1M Return | -14.49% |
| From 52W High | -73.78% |
| 1Y MDD | -73.06% |
| Trading | |
| Volume | 68,415 shares |
| Foreign Own. | 1.37% |
| Per Share | |
| EPS | -326 KRW |
| BPS | 759 KRW |
Company Info
Established in 1999 based on poly-gamma-glutamic acid source technology, the company is a bio new drug development firm listed on KOSDAQ in 2016. Utilizing HumaMAX and MucoMAX platforms, it focuses on new drug development and operates in health functional foods, functional cosmetics, pet care, and pharmaceutical distribution. The company holds a pipeline for rare disease treatments and manufactures and distributes health functional foods and functional cosmetics using immune-boosting functional ingredients.